Clinical characteristics, management, and outcome of eosinophilic pneumonia associated with daptomycin

Heidary, 2018, Daptomycin, J Antimicrob Chemother, 73, 1, 10.1093/jac/dkx349 Gregoire, 2021, Clinical pharmacokinetics of daptomycin, Clin Pharmacokinet, 60, 271, 10.1007/s40262-020-00968-x Uppal, 2016, Daptomycin-induced eosinophilic pneumonia – a systematic review, Antimicrob Resist Infect Contr, 5 Suzuki, 2019, Eosinophilic pneumonia: a review of the previous literature, causes, diagnosis, and management, Allergol Int, 68, 413, 10.1016/j.alit.2019.05.006 Krabansky, 2018, Eosinophilic pneumonia induced by non-steroidal anti-inflammatory drugs: an underestimated risk, Therapie, 73, 473, 10.1016/j.therap.2018.03.005 Kim, 2012, Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports, Drug Saf, 35, 447, 10.2165/11597460-000000000-00000 Bartal, 2018, Drug-induced eosinophilic pneumonia: a review of 196 case reports, Medicine (Baltimore), 97, e9688, 10.1097/MD.0000000000009688 Cobb, 2007, Organizing pneumonia and pulmonary eosinophilic infiltration associated with daptomycin, Ann Pharmacother, 41, 696, 10.1345/aph.1H372 Hayes, 2007, Eosinophilic pneumonia induced by daptomycin, J Infect, 54, e211, 10.1016/j.jinf.2006.11.006 Kakish, 2008, Acute respiratory failure due to daptomycin induced eosinophilic pneumonia, Respir Med CME, 1, 235, 10.1016/j.rmedc.2008.07.010 Shinde, 2009, Daptomycin-induced pulmonary infiltrates with eosinophilia, J Infect, 58, 173, 10.1016/j.jinf.2008.11.001 Kalogeropoulos, 2011, Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature, J Med Case Rep, 5, 13, 10.1186/1752-1947-5-13 Rether, 2011, A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia, Infection, 39, 583, 10.1007/s15010-011-0148-y Patel, 2014, Daptomycin-induced acute eosinophilic pneumonia, WMJ, 113, 199 Yamamoto, 2014, Daptomycin-induced pneumonitis in a patient with chronic obstructive pulmonary disease (COPD), Intern Med, 53, 2559, 10.2169/internalmedicine.53.3058 Lin, 2015, Host cell-catalyzed S-palmitoylation mediates golgi targeting of the legionella ubiquitin ligase GobX, J Biol Chem, 25766, 10.1074/jbc.M115.637397 Hagiya, 2015, Myopathy and eosinophilic pneumonia coincidentally induced by treatment with daptomycin, Intern Med, 54, 525, 10.2169/internalmedicine.54.3397 Roux, 2015, Daptomycin-induced eosinophilic pneumonia, Int J Infect Dis, 37, 95, 10.1016/j.ijid.2015.06.010 Wojtaszczyk, 2015, Dyspnea on daptomycin: eosinophilic pneumonia, R I Med J (2013), 98, 41 Akcaer, 2016, Eosinophilic pneumonia: daptomycin-induced lung complication, Med Mal Infect, 46, 166, 10.1016/j.medmal.2016.01.006 Hatipoglu, 2016, Possible daptomycin-induced acute eosinophilic pneumonia in a patient with diabetic foot infection, Int J Antimicrob Agents, 47, 414, 10.1016/j.ijantimicag.2016.02.014 Montenegro, 2016, Acute eosinophilic pneumonia secondary to daptomycin, Enferm Infecc Microbiol Clin, 34, 390, 10.1016/j.eimc.2015.08.010 Zaccarini, 2016, Poster 53 daptomycin-induced acute eosinophilic pneumonia in a patient receiving rehabilitation post prosthetic joint infection: a case report, PMR, 8, S178 Nickerson, 2017, Daptomycin-associated eosinophilic pneumonia with rechallenge: a case report, Int J Clin Pharmacol Ther, 55, 521, 10.5414/CP202952 Abelenda, 2018, Daptomycin eosinophilic pneumonia: an adverse effect to be aware of, Rev Esp Quimioter, 31, 282 Basnet, 2018, Daptomycin associated eosinophilic pneumonia: case report and differential diagnoses, J Community Hosp Intern Med Perspect, 8, 152, 10.1080/20009666.2018.1475188 Higashi, 2018, Daptomycin-induced eosinophilic pneumonia and a review of the published literature, Intern Med, 57, 253, 10.2169/internalmedicine.9010-17 Kumar, 2018, Daptomycin-induced acute eosinophilic pneumonia, Cureus, 10, e2899 Raza, 2019, Unexpected outcome of daptomycin-induced eosinophilic pneumonia: rarity within a rarity, Cureus, 11, e6271 Storandt, 2020, Acute eosinophilic pneumonia: a rare complication of daptomycin therapy, Cureus, 12, e6803 Zimmer, 2020, Daptomycin-induced eosinophilic pneumonia associated with an early endoprosthesis infection, Anaesthesist, 69, 414, 10.1007/s00101-020-00765-y Portalatin, 2021, Daptomycin-induced acute eosinophilic pneumonia, Cureus, 13, e13509 Raman, 2021, Eosinophilic pneumonia: a case of daptomycin induced lung injury, J Community Hosp Intern Med Perspect, 11, 280, 10.1080/20009666.2021.1883813 Watts, 2021, Multifocal pneumonia amidst the global COVID-19 pandemic: a case of daptomycin-induced eosinophilic pneumonia, Cureus, 13, e16002 Lal, 2010, Two cases of daptomycin-induced eosinophilic pneumonia and chronic pneumonitis, Clin Infect Dis, 50, 737, 10.1086/650487 Miller, 2010, Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases, Clin Infect Dis, 50, e63, 10.1086/652656 Phillips, 2013, Daptomycin-induced acute eosinophilic pneumonia: analysis of the current data and illustrative case reports, Scand J Infect Dis, 45, 804, 10.3109/00365548.2013.805427 Yusuf, 2014, Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection, Surg Infect, 15, 834, 10.1089/sur.2013.200 Chiu, 2015, Daptomycin-induced eosinophilic pneumonia treated with intravenous corticosteroids, J Pharmacy Pract, 28, 275, 10.1177/0897190014568678 Hirai, 2017, Eosinophilic pneumonia caused by daptomycin: six cases from two institutions and a review of the literature, J Infect Chemother, 23, 245, 10.1016/j.jiac.2016.09.001 Raru, 2018, Two patients with daptomycin induced eosinophilic pneumonia with different presentations and treatment, Respir Med Case Rep, 23, 29 Naranjo, 1981, A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther, 30, 239, 10.1038/clpt.1981.154 Solomon, 2006, Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia, Semin Respir Crit Care Med, 27, 192, 10.1055/s-2006-939522 FDA Drug Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin); 2010. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin [accessed 9.9.19]. Allen, 2004, Drug-induced eosinophilic lung disease, Clin Chest Med, 25, 77, 10.1016/S0272-5231(03)00141-2 Jhun, 2014, Clinical implications of correlation between peripheral eosinophil count and serum levels of IL-5 and tryptase in acute eosinophilic pneumonia, Respir Med, 108, 1655, 10.1016/j.rmed.2014.09.011 Katoh, 2004, Elevated interleukin-18 levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia, Allergy, 59, 850, 10.1111/j.1398-9995.2004.00492.x Mato, 2013, Clinical significance of interleukin 33 (IL-33) in patients with eosinophilic pneumonia, Allergol Int, 62, 45, 10.2332/allergolint.12-OA-0439 De Giacomi, 2018, Acute eosinophilic pneumonia. Causes, diagnosis, and management, Am J Resp Crit Care, 197, 728, 10.1164/rccm.201710-1967CI Mikerov, 2008, Sex differences in the impact of ozone on survival and alveolar macrophage function of mice after Klebsiella pneumoniae infection, Respir Res, 9, 24, 10.1186/1465-9921-9-24 Hardin, 2016, Sex-specific features of emphysema among current and former smokers with COPD, Eur Respir J, 47, 104, 10.1183/13993003.00996-2015 Mauvais-Jarvis, 2020, Sex and gender: modifiers of health, disease, and medicine, Lancet, 396, 565, 10.1016/S0140-6736(20)31561-0 Soldevila-Boixader, 2021, Risk factors of daptomycin-induced eosinophilic pneumonia in a population with osteoarticular infection, Antibiotics (Basel), 10 Walski, 2009, Pulmonary surfactant: ultrastructural features and putative mechanisms of aging, J Physiol Pharmacol, 60, 121